Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review

Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH66572FSA
  • |
  • Pages: 56
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company's products are built on its proprietary polymer-based technologies: Micropump, an oral sustained release microparticles platform, LiquiTime, a Micropump - derived platform for liquid oral products, Trigger Lock, a Micropump - derived platform that enables abuse-resistant modified and controlled release formulations and Medusa that enables controlled release of injectables. It sells its products in the US, France, and Ireland. The company operates in St. Louis, Missouri, and Charlotte in the US. Avadel is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals Plc Key Recent Developments

Aug 07,2018: Avadel Pharmaceuticals reports second quarter 2018 financial results

May 02,2018: Avadel Pharmaceuticals Reports First Quarter 2018 Results

Mar 22,2018: Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer

Mar 08,2018: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results

Dec 29,2017: Avadel Pharmaceuticals Issues 2018 Corporate Outlook

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Avadel Pharmaceuticals Plc - Key Facts 6

Avadel Pharmaceuticals Plc - Key Employees 7

Avadel Pharmaceuticals Plc - Key Employee Biographies 8

Avadel Pharmaceuticals Plc - Major Products and Services 9

Avadel Pharmaceuticals Plc - History 10

Avadel Pharmaceuticals Plc - Company Statement 13

Avadel Pharmaceuticals Plc - Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2 - Company Analysis 17

Company Overview 17

Avadel Pharmaceuticals Plc - Business Description 18

Product Category: Akovaz 18

Overview 18

Performance 18

Product Category: Bloxiverz 18

Overview 18

Performance 18

Product Category: Vazculep 18

Overview 18

Performance 18

Product Category: License and Research Revenue 18

Performance 18

Product Category: Other 19

Performance 19

R&D Overview 19

Avadel Pharmaceuticals Plc - Corporate Strategy 20

Avadel Pharmaceuticals Plc - SWOT Analysis 21

SWOT Analysis - Overview 21

Avadel Pharmaceuticals Plc - Strengths 21

Avadel Pharmaceuticals Plc - Weaknesses 22

Avadel Pharmaceuticals Plc - Opportunities 23

Avadel Pharmaceuticals Plc - Threats 24

Avadel Pharmaceuticals Plc - Key Competitors 25

Section 3 - Company Financial Ratios 26

Financial Ratios - Capital Market Ratios 26

Financial Ratios - Annual Ratios 27

Performance Chart 30

Financial Performance 30

Financial Ratios - Interim Ratios 31

Financial Ratios - Ratio Charts 32

Section 4 - Company's Lifesciences Financial Deals and Alliances 33

Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

Avadel Pharmaceuticals Plc, Recent Deals Summary 35

Section 5 - Company's Recent Developments 36

Aug 07, 2018: Avadel Pharmaceuticals reports second quarter 2018 financial results 36

May 02, 2018: Avadel Pharmaceuticals Reports First Quarter 2018 Results 38

Mar 22, 2018: Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer 40

Mar 08, 2018: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results 41

Dec 29, 2017: Avadel Pharmaceuticals Issues 2018 Corporate Outlook 42

Nov 08, 2017: Avadel Pharmaceuticals Reports Third Quarter 2017 Results 44

Aug 08, 2017: Avadel Pharmaceuticals Reports Second Quarter 2017 Results 46

May 09, 2017: Avadel Pharmaceuticals Reports First Quarter 2017 Results 48

Mar 30, 2017: Avadel Pharmaceuticals Announces Planned Reduction of French Workforce 49

Mar 07, 2017: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results 50

Section 6 - Appendix 52

Methodology 52

Ratio Definitions 52

About GlobalData 56

Contact Us 56

Disclaimer 56

List of Figures

Avadel Pharmaceuticals Plc, Performance Chart (2013 - 2017) 30

Avadel Pharmaceuticals Plc, Ratio Charts 32

Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 34

List of Tables

Avadel Pharmaceuticals Plc, Key Facts 6

Avadel Pharmaceuticals Plc, Key Employees 7

Avadel Pharmaceuticals Plc, Key Employee Biographies 8

Avadel Pharmaceuticals Plc, Major Products and Services 9

Avadel Pharmaceuticals Plc, History 10

Avadel Pharmaceuticals Plc, Subsidiaries 15

Avadel Pharmaceuticals Plc, Key Competitors 25

Avadel Pharmaceuticals Plc, Ratios based on current share price 26

Avadel Pharmaceuticals Plc, Annual Ratios 27

Avadel Pharmaceuticals Plc, Annual Ratios (Cont...1) 28

Avadel Pharmaceuticals Plc, Annual Ratios (Cont...2) 29

Avadel Pharmaceuticals Plc, Interim Ratios 31

Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

Avadel Pharmaceuticals Plc, Recent Deals Summary 35

Currency Codes 52

Capital Market Ratios 52

Equity Ratios 53

Profitability Ratios 53

Cost Ratios 54

Liquidity Ratios 54

Leverage Ratios 55

Efficiency Ratios 55

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Veloxis Pharmaceuticals Inc

Elite Pharmaceuticals Inc

DURECT Corp

Depomed Inc

Albireo Pharma Inc

Acura Pharmaceuticals Inc

Avadel Pharmaceuticals Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8990
Site License
USD 250 INR 17980
Corporate User License
USD 375 INR 26970

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com